MHRA Drug Safety Update February 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 7 February 2022) has been published and includes articles on:

  • COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry
  • Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions
  • Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing
  • COVID-19 vaccines and medicines: updates for February 2021
  • Letters and medicine recalls sent to healthcare professionals in January 2022

To see the latest MHRA Drug Safety Updates in full, visit the website

Support the call for more funding by recording information about the informal advice you provide to patients over just one day.

Click Here